UKRI – Nucleic acid medicines manufacture receives £4.5m in funding
Five projects will receive funding to develop and commercialise innovative solutions for the manufacturing of nucleic acid medicines.
Innovate UK announces today the winners of a funding competition to create and bring to market inventive approaches while enhancing the resource effectiveness, output and expandability for producing nucleic acid medications.
Published on the 09th of May 2024. Find the entire news report here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (4 novembre 2024). UKRI – Nucleic acid medicines manufacture receives £4.5m in funding. ELSIBI. Consulté le 9 décembre 2024 à l’adresse https://doi.org/10.58079/12m6t
